Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05724433
Other study ID # VICTORY-HF RCT (Pilot Phase)
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date December 9, 2022
Est. completion date November 30, 2023

Study information

Verified date February 2023
Source Population Health Research Institute
Contact Harriette GC Van Spall, MD MPH
Phone (905) 521-2100
Email Harriette.VanSpall@phri.ca
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Heart failure (HF) is a leading cause of death, hospitalization, and healthcare system expenditure in Canada. While care in HF clinics - multidisciplinary clinics that focus on optimal management of HF - improves health outcomes in HF, there are disparities in access to such care across our province. To respond to the needs of patients and the health care system, the investigators propose to develop and implement a virtual model of care that will enable Canadians with HF to receive outpatient HF care and medical optimization remotely. The investigators will assess the feasibility of this model of care in a pilot randomized controlled trial, and collect feedback from patients and providers. The investigators hypothesize that virtual clinics will be feasible. The investigators will also measure healthcare processes, and use these to guide a larger clinical trial that will measure clinical outcomes in patients receiving virtual versus usual care.


Recruitment information / eligibility

Status Recruiting
Enrollment 50
Est. completion date November 30, 2023
Est. primary completion date June 9, 2023
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: Adult patients = 18 years old who: 1. are being discharged after hospitalization or urgent visit (emergency department) for HF OR have been referred for an initial consult at a cardiology clinic within 30 days of hospitalization or urgent visit for HF 2. have left ventricular ejection fraction (LVEF) < 55% within the preceding 3 months 3. Have NT-proBNP of > 900 pg/ml 4. have a mailing address for the patient or caregiver 5. are competent (either independently or with caregiver) in using the virtual care platform during a brief demonstration 6. provide consent.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Virtual HF Care
Patients will receive virtual visits for 3 months following hospitalization / emergency department (ED) visit for HF. Physiologic measures will be monitored remotely and therapies will be optimized.
Routine HF Care
Care as determined by the treating physician

Locations

Country Name City State
Canada Hamilton General Hospital Hamilton Ontario
Canada Juravinski Hospital Cancer Centre Hamilton Ontario
Canada St. Joseph's Healthcare Hamilton Hamilton Onatrio

Sponsors (3)

Lead Sponsor Collaborator
Population Health Research Institute Hamilton Health Sciences Corporation, McMaster University

Country where clinical trial is conducted

Canada, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in heath status 90 days
Secondary Number of patients randomized 90 days
Secondary Proportion of patients allocated to the virtual HF clinic who require crossover to the routine HF clinic 90 days
Secondary Proportion of patients that are seen in clinic within 7 days post discharge date of discharge to 7 days
Secondary Proportion of patients on all classes of guideline-directed medical therapy (GDMT) at baseline, 30 days and 90 days 90 days
Secondary Proportion of patients who have heath status data collected at baseline, 30 days and 90 days 90 days
Secondary Qualitative feedback on patient satisfaction and usability of technology 90 days
Secondary Number of visits per patient during 90 days 90 days
See also
  Status Clinical Trial Phase
Recruiting NCT05650307 - CV Imaging of Metabolic Interventions
Recruiting NCT05654272 - Development of CIRC Technologies
Recruiting NCT05196659 - Collaborative Quality Improvement (C-QIP) Study N/A
Active, not recruiting NCT05896904 - Clinical Comparison of Patients With Transthyretin Cardiac Amyloidosis and Patients With Heart Failure With Reduced Ejection Fraction N/A
Completed NCT05077293 - Building Electronic Tools To Enhance and Reinforce Cardiovascular Recommendations - Heart Failure
Recruiting NCT05631275 - The Role of Bioimpedance Analysis in Patients With Chronic Heart Failure and Systolic Ventricular Dysfunction
Enrolling by invitation NCT05564572 - Randomized Implementation of Routine Patient-Reported Health Status Assessment Among Heart Failure Patients in Stanford Cardiology N/A
Enrolling by invitation NCT05009706 - Self-care in Older Frail Persons With Heart Failure Intervention N/A
Recruiting NCT04177199 - What is the Workload Burden Associated With Using the Triage HF+ Care Pathway?
Terminated NCT03615469 - Building Strength Through Rehabilitation for Heart Failure Patients (BISTRO-STUDY) N/A
Recruiting NCT06340048 - Epicardial Injection of hiPSC-CMs to Treat Severe Chronic Ischemic Heart Failure Phase 1/Phase 2
Recruiting NCT05679713 - Next-generation, Integrative, and Personalized Risk Assessment to Prevent Recurrent Heart Failure Events: the ORACLE Study
Completed NCT04254328 - The Effectiveness of Nintendo Wii Fit and Inspiratory Muscle Training in Older Patients With Heart Failure N/A
Completed NCT03549169 - Decision Making for the Management the Symptoms in Adults of Heart Failure N/A
Recruiting NCT05572814 - Transform: Teaching, Technology, and Teams N/A
Enrolling by invitation NCT05538611 - Effect Evaluation of Chain Quality Control Management on Patients With Heart Failure
Recruiting NCT04262830 - Cancer Therapy Effects on the Heart
Completed NCT06026683 - Conduction System Stimulation to Avoid Left Ventricle Dysfunction N/A
Withdrawn NCT03091998 - Subcu Administration of CD-NP in Heart Failure Patients With Left Ventricular Assist Device Support Phase 1
Recruiting NCT05564689 - Absolute Coronary Flow in Patients With Heart Failure With Reduced Ejection Fraction and Left Bundle Branch Block With Cardiac Resynchronization Therapy